Filtered By:
Vaccination: Cervical Cancer Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 98 results found since Jan 2013.
Oral warts in a pediatric patient with trisomy 21 successfully treated with human papillomavirus vaccine
We present the case of a 5-year-old male with Trisomy 21 with extensive oral warts successfully treated with Recombinant Human Papillomavirus vaccination.
Source: Annals of Allergy, Asthma and Immunology - November 1, 2022 Category: Allergy & Immunology Authors: R. Grohman, E. Fox, S. Loeber, R. Eisenberg Tags: M261 Source Type: research
M024 don ’t stop hpv vaccine with one dose left, go see an allergist!
HPV is the most common sexually transmitted infection in the US. HPV is associated with cervical, vulvar, and vaginal cancer in females, penile cancer in males, and anal and oropharyngeal cancer in both females and males. FDA-approved in 2014, human papillomavirus vaccine (9vHPV, Merck), aids in the prevention of diseases caused by nine types of HPV. 9vHPV is now licensed in the US for females and males ages 9 through 45 years. For those 15 years and older, a 3-dose schedule is recommended.
Source: Annals of Allergy, Asthma and Immunology - November 1, 2021 Category: Allergy & Immunology Authors: M. Lukas, M. Tankersley Source Type: research
Designing of DNA Vaccine Based on a Secretory Form of Major Capsid Protein of Human Papillomavirus Type 18
In conclusion, pVAX1-tPA-PADRE-L1 recombinant plasmid is a highly immunogenic construct and suggests as a promising candidate for vaccine development against HPV type 18 in low-middle-income countries.PMID:34664812 | DOI:10.18502/ijaai.v20i5.7403
Source: Iranian Journal of Allergy, Asthma and Immunology - October 19, 2021 Category: Allergy & Immunology Authors: Somayeh Shokri Shahab Mahmoudvand Manoochehr Makvandi Reza Taherkhani Mohammad Rashno Farid Azizi Jalilian Kambiz Ahmadi Angali Mohammad Ali Foroughi Source Type: research
